Form 8-K - Current report:
SEC Accession No. 0001564590-18-022422
Filing Date
2018-08-29
Accepted
2018-08-29 08:34:44
Documents
3
Period of Report
2018-08-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20180829.htm 8-K 30056
2 EX-99.1 xene-ex991_7.htm EX-99.1 30088
3 GRAPHIC gde5z2ggwsdk000001.jpg GRAPHIC 13001
  Complete submission text file 0001564590-18-022422.txt   79276
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 181042996
SIC: 2834 Pharmaceutical Preparations